Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Sarcoma 1Plasma cell 1Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Sarcoma 13Melanoma 5Lung Neoplasms 3Breast Neoplasms 3Sarcoma, Synovial 2Ovarian Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Desmoplastic Small Round Cell Tumor 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Bone Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma, Endometrial Stromal 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Neurofibrosarcoma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma 1Liver Neoplasms 1Liposarcoma 1

Interventions

pembrolizumab 3Oncolytic Virotherapy 2Fluorouracil 2Cyclophosphamide 2Cetuximab 2trebananib 1spartalizumab 1repotrectinib 1pemigatinib 1patritumab 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1darinaparsin 1apatinib 1Tetanus Toxoid 1Sirolimus 1Paclitaxel 1Mesna 1Ipilimumab 1Injections 1Etoposide 1Cisplatin 1Celecoxib 1Carboplatin 1Blood Specimen Collection 1Ascorbic Acid 12,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Injections × Sarcoma × Clear all
NCT01125449 2025-05-18

Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease

Situs Cancer Research Center

Phase 2 Withdrawn
Plasma cellSarcoma

Adenocarcinoma, Carcinoma, Multiple Myeloma, Sarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡